At week 24 of the year-long study, 14% of patients with early-stage Alzheimer's who received a lower starting dose of the monthly infusion had the brain swelling side effect known as ARIA-E.
Opens in a new tab or window An alternate dosing plan for the anti-amyloid drug donanemab (Kisunla) reduced the risk of brain edema and effusion but still maintained sufficient amyloid reduction ...
Eli Lilly & Co. said that a small change in dosing its Alzheimer’s drug Kisunla cut patients’ rate of brain-swelling side effects in preliminary results from a study. A more gradual increase ...
BRAIN-swelling 'sloth fever' could be passed on in the womb, experts fear. Their warning comes after a mum tragically lost her baby before it was born, following infection with the virus.
A small tweak in the dosing regimen of Eli Lilly’s Alzheimer’s disease drug Kisunla has reduced brain swelling of patients in a trial, the company said Tuesday. In the phase 3 study ...
Approved by the FDA in July to treat adults with early symptomatic Alzheimer’s disease, Eli Lilly’s Kisunla reduced the brain swelling of patients in a late-stage trial following an adjusted dosing ...
CHICAGO (Reuters) - Starting on a more gradual dosing schedule of Eli Lilly's Alzheimer's drug Kisunla cut the percentage of patients experiencing potentially serious brain swelling, according to ...
Jennifer and her partner rushed the dogs to the vets where they were given injections to induce vomiting but Opi is thought to have life-threatening injuries due to brain swelling and internal ...